MyFinsight
Home
Blog
About
Back
Income Statement
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)
source: myfinsight.com
Nuplazid
$183,132K
(8.70%↑ Y/Y)
Daybue
$124,827K
(29.91%↑ Y/Y)
Total revenues
$307,959K
(16.40%↑ Y/Y)
Income from operations
$37,836K
(16.87%↑ Y/Y)
Interest income, net
$7,990K
(10.31%↑ Y/Y)
Other income
$647K
(8.92%↑ Y/Y)
Total operating
expenses
$270,123K
(16.34%↑ Y/Y)
Income before income
taxes
$46,473K
(15.57%↑ Y/Y)
Selling, general and
administrative
$160,252K
(20.03%↑ Y/Y)
Research and development
$81,555K
(4.62%↑ Y/Y)
Cost of product sales
$28,316K
(36.57%↑ Y/Y)
Net loss
$31,500K
(18.13%↑ Y/Y)
Income tax expense
$14,973K
(10.54%↑ Y/Y)
Back